Felbamate (FBM) is used to treat partial seizures and Lennox–Gastaut syndrome.
Black box warning was added because of fatal cases of aplastic anemia and liver failure.
We retrospectively analyzed FBM's safety and efficacy in 103 patients with epilepsy.
FBM was reasonably safe and effective to treat epilepsy.